Human Pheromone Sciences (EROX) Stock Price, News & Analysis

Company Overview

Human Pheromone Sciences, Inc., doing business as EROX, is a development‐stage company focused on the research, development and commercialization of consumer products based on human pheromone science. The company’s core business activity centers on formulating and marketing topical fragrances and perfumes that incorporate proprietary pheromone blends intended to enhance personal appeal. Its product lines are designed for direct‐to‐consumer sale through e‐commerce platforms and selected retail partnerships.

In addition to finished personal care products, Human Pheromone Sciences pursues formulation and licensing agreements that leverage its in-house expertise in volatile compound chemistry. The company holds or licenses patents and trademarks related to its pheromone delivery systems and works with contract manufacturers to ensure consistent quality and scalability. While still in early stages of market penetration, EROX aims to expand its portfolio beyond fragrances into adjacent wellness categories that utilize pheromone technology.

Headquartered in Delaware, Human Pheromone Sciences currently serves primarily the North American market but has indicated plans to explore distribution channels in Europe and Asia as part of its longer-term growth strategy. Although publicly traded on the OTC Pink market under the ticker EROX, detailed information on executive leadership and financial metrics remains limited. As a niche player in the personal care sector, the company continues to develop both its research pipeline and consumer-facing brands in pursuit of broader market adoption.

Key Stats

• Today's Range: $0.0004 to $0.0004
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.13
• Volume: N/A
• Average Volume: 13,574 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EROX Stock Analysis - Frequently Asked Questions

How have EROX shares performed this year?

Human Pheromone Sciences' stock was trading at $0.0004 on January 1st, 2025. Since then, EROX shares have increased by 0.0% and is now trading at $0.0004.

How do I buy shares of Human Pheromone Sciences?

Shares of EROX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/16/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Toilet Preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EROX
• CIK: N/A
• Web: www.naturalattraction.com
• Phone: (408) 938-3030
• Fax: 408-938-3025
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 3.30